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As the editors of several journals, we have joined forces to highlight the importance of 
providing essential details related to animal experiments, particularly for studies that include 
mouse work. This is a critical issue that partially underlies the problem of irreproducible 
results that is attracting international attention1 as well as the attention of funding agencies 
such as the National Institutes of Health.2 For mouse studies, this can be a daunting problem 
given that many manuscripts do not provide sufficient details regarding the number of 
animals used for a given experiment, the sex of the animals, their age, and in some cases 
identification of the background genetic strains. Other variables that can also play an 
important role in shaping experimental findings and conclusions are the microbiome,3 
making co-housing of control and genetically altered animals essential, diet, and even the 
composition of animal bedding.4 
 
Several journals have supported the ARRIVE (Animal Research: Reporting of In Vivo 
Experiments) Guidelines that were originally proposed in 2010,5 which include an extensive 
checklist of information related to animal experiments that is considered essential to provide. 
However, it seems that the reporting standards may not have improved very much since 
initial presentation and acceptance of the guidelines by multiple journals.6 Several reasons 
may account for the observed ‘noncompliance’ with the ARRIVE guidelines,6 including 
difficulty ensuring that reviewers and editors carefully assess whether the guidelines have 
been followed, and the possibility that some authors may indicate that the guidelines have 
been followed (based on author interpretation and not because of any malintent) when in 
reality not all components have been pursued. Reviewers and editors frequently ask authors 
to expand on some of these necessary details, but the reviewers often focus on separate 
important issues while the specifics that are related to the mouse work may be overlooked. 
Another barrier might be the extensive nature of the ARRIVE checklist, which may not apply 
fully to many submitted manuscripts. This is relevant, because scientists (and physicians) are 
now facing an increasing barrage of regulatory documentation paperwork that is limiting 
their time for scientific investigation (or for their patients). Notwithstanding this limitation, 
we are uniting from different journals to highlight the importance of documenting what we 
consider to be the minimum list of information to improve transparency and the quality of 
data reporting. Our purpose is not to legislate a “one size fits all” philosophy, but rather to 
maximize the possibility of other researchers reproducing study findings from the same wild-
type or mutant mouse strains. Our respective journals will be highlighting the criteria listed 
below in our Instructions to Authors, and some of our journals will also introduce an author-
friendly checklist that will need to accompany manuscripts that use mice and other in vivo 
experimental models. 
 
The criteria that will be expected of authors include the following information (Figure 1): 
 Sex and age of mice (or other in vivo experimental models) for all the experiments;  
 The genetic background(s) of the mice or other experimental in vivo models; 
 For transgenic or genetic mouse models, whether the controls were sibling littermates or 
were purchased separately (if purchased separately, were the animals cohoused to minimize 
potential microbiome effects); 
 Specifics of the animal diet composition; 
 Whether mice were fasted (and for how long) or not before a challenge or assessment is 
carried out; 
 Type of bedding, caging system, and enrichment used for housing the mice; and 
 If interventions were done, were they done during the light or dark cycle. 
 Power analyses can be useful to estimate appropriate sample sizes; however, the standard 
deviations for relevant dependent variables are often not known a priori. Therefore, it is 
critical that the number of animals for each experimental arm or condition is reported 
together with biological replication of statistically significant results derived from 
independent groups of animals. 
 
There are also other variables that may need to be considered that we have not included as 
primary expectations, particularly those related to behavior, stress, and growth conditions. 
These variables include acclimation to a new environment (eg, when animals are shipped by 
the vendor or moved from the animal facility to a procedure room), other environment effects 
(eg, temperature, humidity, noise), littermate size, and pheromone effects. These additional 
variables can be very important depending on the biologic readout. Moreover, environment 
effects, such as avoidance of large temperature changes unless approved as part of an animal 
protocol, are expected to be part of the normal procedures of humane treatment of animals. 
 
What can journals and research institutions do moving forward toward a path to 
implementation?7 Certainly all stakeholders need to be engaged and many funding agencies 
now expect that applicants pay closer attention to this important issue, as exemplified by the 
recent requirement from the National Institutes of Health to include a section titled 
Authentication of Key Biological and/or Chemical Resources in grant applications.8 For 
journals, setting and enforcing clear expectations to authors, reviewers, and editors will be 
essential, because a checklist alone will not be sufficient, while making the process as user-
friendly as possible. For institutions, several approaches can be considered and implemented, 
that are aimed at investigators and trainees. For example, the curricula for students who are 
enrolled in bioscience-related undergraduate and graduate programs should include training 
not only in the ethics in conducting research, but also in the basic tenets of conducting and 
designing animal experiments. It is important for this to start early and to be reinforced as 
training advances. Similarly, postdoctoral fellows in biomedical disciplines should be 
expected to enroll in similar workshops that would be offered by their home institutions. For 
such workshops, centralized (rather than department- or unit-specific) oversight and 
administration will more likely ensure uniformity and implementation. We look forward to 
working together on this important effort and to receiving feedback from our authors, 
reviewers and readers. 
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Figure 1.Key elements to consider and highlight for mouse related studies. The schematic 
shows several important criteria that need to be considered when planning mouse (and other 
animal) experiments, and when submitting work for publication. FVB and C57BL/6 
represent, as examples, commonly used mouse strains. Of note, vendor sources can also be 
important (eg, FVB/NJ from The Jackson Laboratory vs FVB/NTac from Taconic). Other 
considerations not displayed in the schematic, such as environment conditions, are 
highlighted in the text. +/+, wild-type littermate mice; -/-, knockout littermate mice. 
